Identification of Mutator-Derived lncRNA Signatures of Genomic Instability for Promoting the Clinical Outcome in Hepatocellular Carcinoma

Figure 3

Prognosis model of mutator-derived lncRNA signature. (a) The six prognostic-related GIlncRNAs calculated by univariate Cox regression. (b, c) The process of Lasso regression that we screened out two of the six prognostic-related GIlncRNAs. (d) The four mutator-derived lncRNAs were finally selected and their coefficients. (e–h) The K-M analysis of four mutator-derived lncRNAs. (i) The K-M analysis of HCC patients based on the GILncSig, and the OS of patients in the low-risk group is significantly better than patients in the high-risk group.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)